Physician profile
Alesha Pennington
NPI 1578849618
$1,682.97
in general payments reported to CMS, 2019-2025
26 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $434 · 2023: $505 · 2024: $178 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957 · Education: $92.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.33 |
| Education | $92.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $359.23 | 2021-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $209.59 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $149.13 | 2022-2025 | |
| Hologic Sales and Service, LLC | $124.17 | 2022-2025 | Aptima, Novasure, Acessa Provu System |
| Abbvie INC. | $122.34 | 2021-2025 | |
| Astellas Pharma US INC | $89.90 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $63.00 | 2022-2023 | Slynd |
| Sage Therapeutics, LLC | $58.75 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $58.49 | 2023 | Myfembree |
| Organon LLC | $55.47 | 2022-2025 | Nexplanon |
| Exact Sciences Corporation | $45.55 | 2023-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $41.79 | 2025 | |
| Pfizer INC. | $40.22 | 2021-2022 | |
| Axonics, INC. | $35.04 | 2023 | Axonics |
| Convatec INC. | $34.53 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $23.58 | 2021-2022 | |
| Ortho-Clinical Diagnostics, INC. | $22.41 | 2024 | |
| Alexion Pharmaceuticals, INC. | $21.93 | 2023 | Ultomiris |
| Millicent US INC | $18.73 | 2024 | Intrarosa, Femring |
| Agile Therapeutics, INC. | $17.45 | 2023 | Twirla |
| Gynesonics, INC. | $16.97 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Baxter Healthcare | $16.94 | 2025 | Tisseel |
| Arjo INC. | $15.93 | 2025 | |
| Lilly USA, LLC | $15.81 | 2025 | Zepbound |
| Minerva Surgical, INC | $13.82 | 2023 | |
| Therapeuticsmd, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alesha Pennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.